In today's rapidly evolving business landscape, access to accurate and actionable market intelligence is critical for maintaining competitive advantage. MarketsandMarkets has established itself as a global leader in strategic market ....see more
The pedestrian protection system market is projected to reach USD 8.56 billion by 2033, from USD 6.48 billion in 2026, with a CAGR of 4.1%. The key players include Robert Bosch GmbH (Germany), Aumovio (Germany), Denso Corporation (Japan), ZF Group (Germany), and Aptiv (Ireland).
The Asia Pacific centrifugal pump market is estimated to reach USD 26.17 billion by 2030, growing from USD 18.86 billion in 2025, with a CAGR of 6.8% during the forecast period (2025-2030). Some of the major players in the Asia Pacific centrifugal pump market are Xylem (US), Grundfos Holding A/S (Denmark), Flowserve Corporation (US), KSB SE & Co. KGaA (Germany), Wilo SE (Germany).
The UK next-generation sequencing market is projected to grow from USD 795.8 million in 2026 to USD 1,587.2 million by 2031, at a CAGR of 14.8% during the forecast period. The report profiles key players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Oxford Nanopore Technologies plc. (UK), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (US), and Eurofins Scientific (Luxembourg).
The US centrifugal pump market is projected to reach USD 9.85 billion by 2030 from an estimated USD 7.16 billion in 2025, at a CAGR of 6.6% during the forecast period. Leading manufacturers such as Xylem Inc., Flowserve Corp., ITT Corp., Grundfos, and KSB SE & Co. KGaA have an expansive presence throughout the US, including significant operations for manufacturing, distribution, and after-sales services.
The electric centrifugal pump market is projected to reach USD 45.44 billion by 2030 from USD 33.07 billion in 2025, at a CAGR of 6.6% during the forecast period. The key players include Grundfos (Denmark), Xylem (US), Ebara Corporation, Flowserve Corporation, ITT Inc.
Injectable Pharma Packaging Market is projected to reach USD 98.8 billion by 2030 from USD 44.8 billion in 2025, at a CAGR of 17.5% during the forecast period. The key players in the injectable pharma packaging market include Schott AG (Germany), Gerresheimer AG (Germany), West Pharmaceutical Services (US), Stevanato Group (Italy), BD (Becton, Dickinson and Company) (US), SGD Pharma (France), Nipro Corporation (Japan), AptarGroup (US), Catalent, Inc. (US), and Datwyler Group (Switzerland).
The cryogenic vaporizer market is projected to reach USD 0.72 billion by 2031 from USD 0.52 billion in 2026, at a CAGR of 6.5% during the forecast period. The key manufacturers in the cryogenic vaporizer market are Chart Industries (US), Kobe Steel, Ltd. (Japan), Nikkiso Co., Ltd. (Japan), Linde PLC (Ireland), Air Liquide (France), CRYOSPAIN (Spain), INOX India Limited (India), SUMITOMO PRECISION PRODUCTS Co., Ltd. (Japan), Cryostar (France), and Taylor-Wharton (Japan), among others.
The global data center liquid cooling market is estimated at USD 4.07 billion in 2026 and is projected to reach USD 27.65 billion by 2033, at a CAGR of 31.5% from 2026 to 2033. The key players include Rittal GmbH & Co. KG (Friedhelm Loh Group) (Germany), Vertiv Group Corp (US), Green Revolution Cooling Inc. (GRC) (US), Submer (Spain), Schneider Electric (France), Super Micro Computer, Inc. (US), LiquidStack Holding B.V. (Trane Technologies) (US), Iceotope Precision Liquid Cooling (UK), COOLIT SYSTEMS (Canada), Baltimore Aircoil Company Inc. (US).
The Germany Next Generation Sequencing market, valued at USD 0.85 billion in 2025, stood at USD 0.93 billion in 2026 and is projected to advance at a resilient CAGR of 16.0% from 2026 to 2031, culminating in a forecasted valuation of USD 1.96 billion by the end of the period. Next-generation sequencing refers to high-throughput DNA sequencing technologies that are not based on Sanger sequencing.
North America Human Microbiome market, valued at US$0.43 billion in 2024, stood at US$0.78 billion in 2025 and is projected to advance at a resilient CAGR of 32.2% from 2025 to 2031, culminating in a forecasted valuation of US$4.15 billion by the end of the period. New startups in the US and Canada are driving innovation across microbiome therapeutics and diagnostics.
Asia Pacific Pressure Sensitive Adhesives Market
The North America probiotics market is estimated to be USD 14.78 billion in 2025 and is projected to reach USD 21.92 billion by 2030, at a CAGR of 8.2% from 2025 to 2030. The Key ADM (US), Probi USA Inc. (US), Danone North America Public Benefit Corporation (US), International Flavors & Fragrances Inc. (US), Nestle USA (US), Lifeway Foods, Inc. (US), Lactalis American Group, Inc. (US), Kerry Group plc. (Ireland), Now Foods (US), Nature’s Bounty (US), Renewlife (US), Garden of Life (US), Jarrow Formulas, Inc. (US), Kevita (US), and Chobani, LLC. (US).
The North America feed additives market is estimated at USD 11.64 billion in 2025 and is projected to reach USD 14.75 billion by 2030, at a CAGR of 4.8% from 2025 to 2030.The Key Players include Cargill (US), ADM (US), Evonik Industries (Germany), BASF SE (Germany), dsm-firmenich (Switzerland), Ajinomoto Co. (Japan), Novonesis Group (Denmark), Adisseo (France), Nutreco (Netherlands), Kemin Industries (US), Lallemand (Canada), Alltech (US), Bentoli (US), and Novus International (US).
The Asia Pacific Electrosurgery market, valued at USD 1.55 billion in 2024, stood at USD 1.70 billion in 2025 and is projected to advance at a resilient CAGR of 7.9% from 2025 to 2031, culminating in a forecasted valuation of USD 2.69 billion by the end of the period. This is due to rapid technological advancements in electrosurgical instruments and rising demand for minimally invasive procedures.
The Europe Wound Care Market, valued at USD 6.62 billion in 2025, stood at USD 6.98 billion in 2026 and is projected to advance at a resilient CAGR of 6.0% from 2026 to 2031, culminating in a forecasted valuation of USD 9.33 billion by the end of the period. Growth momentum across Europe is fueled by the integration of advanced wound care technologies into European healthcare infrastructure, an emphasis on early diagnosis, and the development of wound care products for chronic and acute wounds.